SARS-CoV-2 proficiency testing kit is designed for use in diagnostic and clinical testing laboratories to aid in the quality assurance of COVID 19 screening. It is produced following ISO/IEC 17043:2010. The PT portfolio allows our test components to offer significant performance data to monitor and prove competency to customers, accreditation bodies or both. Type of PT Scheme: SARS-CoV-2 (SAR) Proficiency Testing
Matrix: Liquid DBS Buffer Solution Analyte/s: Values of analytes vary lot to lot.
All information regarding the use of the SARS-CoV-2 proficiency testing kit can be found in the reporting packet which will be available to download at PT Portal.
COVID 19 Proficiency Testing Kit for use with PCR-based methods that detect the viral RNA by nucleic acid amplification.
Do you have any questions? Explore our FAQs. For more information on this product, please contact our PT Service Team.
Features and Benefits
Samples produced in accordance with ISO 13485
Tubes of positive RNA sequence containing a range from >20 up to 100000 copies/sample
Tubes as negative control
Levels and positive or negative control assignments are unknown to customers
The wide concentration range of samples allows for the effective challenge of the instrument′s sensitivity across its dynamic range
Quick turn / on-demand study options for optimal scheduling convenience
Positive samples have the same sequence as JRC positive sample (EURM-019)
Noninfectious liquid specimen samples, targeting certain CDC and WHO consensus gene sequence regions such as RdRp, N (nucleocapsid), E (envelope) and/or S (spike)
Evaluation of qualitative results as well as quantitative properties such as Cq (Ct) values for semi-quantitative comparison
This “SARS-CoV-2 Proficiency Testing Kit” contains 5 samples “SARS-CoV-2 Sample A” through “E”. Each of these tubes contains relevant CDC and WHO consensus gene sequence regions for the PCR testing in a range from 0 to 500000 copies: RdRp, N (Nucleocapsid, CDC-N1, CDC-N2, CDC-N3, Thailand, Japan), E (Envelope) and S (Spike).
Levels and positive / negative assignments of the individual tubes are unknown.
A safety data sheet (SDS) is available online.
The samples are noninfectious liquid specimens.
Before beginning with the experiment, appropriate methods should be chosen and the procedure must be planned accordingly.
If solutions need to be transferred to other tubes, labeling with a permanent marker is recommended to avoid mix-up between solutions.
There is enough material of each sample to run experiments more than once to confirm the findings.
Remove sample tubes from the refrigerator and allow them to equilibrate at room temperature for 15 min.
Apply the tube to a vortex mixer (or similar device) for approximately 5 sec to fully homogenize the solution.
Centrifuge the mixture for approximately 10 sec and use the volume specified in your RT and PCR testing method directly without further dilution.
To receive qualitative and quantitative evaluations, analyze each tube by your normal testing procedure and report results for the individual samples as Cq / Ct values for the tested gene sequence(s) and as present ("1") or absent ("0") on the report form.
Analytes available to report for can be viewed after logging into supelco-pt.com.
Storage and Stability
Please refer to the sample label for the expiration date, specific storage temperature and specific storage conditions.
Are you new to Supelco Proficiency Testing? Be sure to register your account details in the PT Portal before placing your order. This will provide access to data entry, reporting packets and final reports. Registrations will be approved shortly after your order is placed. For further questions, write to us at firstname.lastname@example.org.
When placing your order online, please indicate your study preference under the ‘your reference′ column. Available studies can be viewed at the bottom of the page. Click here to learn more about Quick-Turn Studies (non-scheduled on-demand proficiency tests that are offered depending on lot availability). The Quick-Turn results are released within 48-72 hours whereas scheduled study reports are released within 21 days.
Final reports for qualitative data will be issued within 48 hours. Quantitative reports will be issued after enough data points have been received to evaluate against a study mean.
Proficiency Testing Schedule (2020-2021)
Analyte: COVID Positive Presence/Absence
SARS-CoV-2 CDC and WHO consensus gene sequence N1 Gene 0-500000 copies N2 Gene 0-500000 copies N3 Gene 0-500000 copies N Gene-Thailand 0-500000 copies N Gene-Japan 0-500000 copies S Gene 0-500000 copies E Gene 0-500000 copies RdRP Gene 0-500000 copies
Kit Components Only
SARS-CoV-2 Sample A
SARS-CoV-2 Sample B
SARS-CoV-2 Sample C
SARS-CoV-2 Sample D
SARS-CoV-2 Sample E
SARS-CoV-2 Sample E
10 - Combustible liquids
Certificate of Analysis
Certificate of Origin
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.